Laboratory Nonconformance (Event) Management - Insights
PACE / State of FL This “Continual Improvement” webinar provides an overview of the event management process deployed by the Mayo Clinic Department of Laboratory Medicine and Pathology.
Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights
By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...
The Emergence of Retail Health: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the...
Mary Jo Williamson shares strategic investment insights with Modern Healthcare - Insights
Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares insights on balancing needs with future-oriented investments.
Check out the second episode of “Life of a Specimen,” a video exploration of the complex path taken by patient samples through testing at Mayo Clinic Laboratories. In this episode, we hear about the quality processes and careful treatment...
hepatitisbtesting-algorithmforscreeningdiagnosismanagement.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2024 Result Profile Table Test ID Test Name HBs antigen HBs antibody (Ab) HBc total Ab HBc IgM Ab HBe antigen...
In 2020, Mayo Clinic Laboratories launched more than 100 new tests. Driven by a patient-centered philosophy, our experts, laboratories, and facilities make it possible to develop new tests that transform medicine worldwide.
New Tests Launched Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Unveiling a novel hemoglobinopathy classification - Insights
In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine...
Visit Mayo Clinic Laboratories at the APA Annual Meeting - Insights
Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and...